Perrigo Company plc’s recently announced acquisition of French consumer health company HRA Pharma will, if it goes through, complete the former’s pivot into a pure self-care player, according to the firm’s UK & Ireland chief Neil Lister.
Expected to close by the end of the first half of 2022, the €1.8bn ($2.1bn) cash deal will be a...







